Global Cell Engineering Service 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI11243298

Publication Date:

November 19, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

Cell engineering services refer to professional services for transforming, cultivating and optimizing cells through a series of biotechnological means, including gene editing, cell line development, cell culture, phenotypic transformation, differentiation and reprogramming. Its purpose is to provide customized cell models and products for scientific research, drug development and treatment, supporting all stages from basic research to clinical application. These services have a wide range of applications in the fields of biopharmaceuticals, regenerative medicine and cell therapy, and have promoted the innovation and development of the life science and pharmaceutical industries.
The global Cell Engineering Service market size is projected to grow from US$ 1115 million in 2024 to US$ 1852 million in 2030; it is expected to grow at a CAGR of 8.8% from 2024 to 2030.
The 鈥淐ell Engineering Service Industry Forecast鈥� looks at past sales and reviews total world Cell Engineering Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell Engineering Service sales for 2023 through 2029. With Cell Engineering Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Engineering Service industry.
This Insight Report provides a comprehensive analysis of the global Cell Engineering Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell Engineering Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Cell Engineering Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Engineering Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Engineering Service.
Cell engineering services are increasingly becoming a core driving force in the field of biopharmaceuticals and regenerative medicine. With the continuous advancement of gene editing technology and cell culture technology, these services have not only accelerated the process of new drug development and personalized treatment, but also promoted the development of cutting-edge fields such as cell therapy and tissue engineering. In the future, cell engineering services will play a more critical role in precision medicine and innovative treatment plans, providing more effective solutions for dealing with complex diseases.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Engineering Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Gene Editing
Cell Line Development
Others
Segmentation by Application:
Medical Industry
Scientific Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Gene Editing
Cell Line Development
Others
Segmentation by Application:
Medical Industry
Scientific Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Portal Biotechnologies
Lonza Group
Thermo Fisher Scientific
Sartorius
GenScript
Metagenomi
CorrectSequence Therapeutics
Eddie Gene

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Cell Engineering Service 麻豆原创 Size 2019-2030
2.1.2 Cell Engineering Service 麻豆原创 Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Cell Engineering Service by Country/Region, 2019, 2023 & 2030
2.2 Cell Engineering Service Segment by Type
2.2.1 Gene Editing
2.2.2 Cell Line Development
2.2.3 Others
2.3 Cell Engineering Service 麻豆原创 Size by Type
2.3.1 Cell Engineering Service 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Cell Engineering Service 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Cell Engineering Service Segment by Application
2.4.1 Medical Industry
2.4.2 Scientific Research
2.4.3 Others
2.5 Cell Engineering Service 麻豆原创 Size by Application
2.5.1 Cell Engineering Service 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Cell Engineering Service 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Cell Engineering Service 麻豆原创 Size by Player
3.1 Cell Engineering Service 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Cell Engineering Service Revenue by Player (2019-2024)
3.1.2 Global Cell Engineering Service Revenue 麻豆原创 Share by Player (2019-2024)
3.2 Global Cell Engineering Service Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cell Engineering Service by Region
4.1 Cell Engineering Service 麻豆原创 Size by Region (2019-2024)
4.2 Global Cell Engineering Service Annual Revenue by Country/Region (2019-2024)
4.3 Americas Cell Engineering Service 麻豆原创 Size Growth (2019-2024)
4.4 APAC Cell Engineering Service 麻豆原创 Size Growth (2019-2024)
4.5 Europe Cell Engineering Service 麻豆原创 Size Growth (2019-2024)
4.6 Middle East & Africa Cell Engineering Service 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Cell Engineering Service 麻豆原创 Size by Country (2019-2024)
5.2 Americas Cell Engineering Service 麻豆原创 Size by Type (2019-2024)
5.3 Americas Cell Engineering Service 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell Engineering Service 麻豆原创 Size by Region (2019-2024)
6.2 APAC Cell Engineering Service 麻豆原创 Size by Type (2019-2024)
6.3 APAC Cell Engineering Service 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cell Engineering Service 麻豆原创 Size by Country (2019-2024)
7.2 Europe Cell Engineering Service 麻豆原创 Size by Type (2019-2024)
7.3 Europe Cell Engineering Service 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cell Engineering Service by Region (2019-2024)
8.2 Middle East & Africa Cell Engineering Service 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Cell Engineering Service 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Cell Engineering Service 麻豆原创 Forecast
10.1 Global Cell Engineering Service Forecast by Region (2025-2030)
10.1.1 Global Cell Engineering Service Forecast by Region (2025-2030)
10.1.2 Americas Cell Engineering Service Forecast
10.1.3 APAC Cell Engineering Service Forecast
10.1.4 Europe Cell Engineering Service Forecast
10.1.5 Middle East & Africa Cell Engineering Service Forecast
10.2 Americas Cell Engineering Service Forecast by Country (2025-2030)
10.2.1 United States 麻豆原创 Cell Engineering Service Forecast
10.2.2 Canada 麻豆原创 Cell Engineering Service Forecast
10.2.3 Mexico 麻豆原创 Cell Engineering Service Forecast
10.2.4 Brazil 麻豆原创 Cell Engineering Service Forecast
10.3 APAC Cell Engineering Service Forecast by Region (2025-2030)
10.3.1 China Cell Engineering Service 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Cell Engineering Service Forecast
10.3.3 Korea 麻豆原创 Cell Engineering Service Forecast
10.3.4 Southeast Asia 麻豆原创 Cell Engineering Service Forecast
10.3.5 India 麻豆原创 Cell Engineering Service Forecast
10.3.6 Australia 麻豆原创 Cell Engineering Service Forecast
10.4 Europe Cell Engineering Service Forecast by Country (2025-2030)
10.4.1 Germany 麻豆原创 Cell Engineering Service Forecast
10.4.2 France 麻豆原创 Cell Engineering Service Forecast
10.4.3 UK 麻豆原创 Cell Engineering Service Forecast
10.4.4 Italy 麻豆原创 Cell Engineering Service Forecast
10.4.5 Russia 麻豆原创 Cell Engineering Service Forecast
10.5 Middle East & Africa Cell Engineering Service Forecast by Region (2025-2030)
10.5.1 Egypt 麻豆原创 Cell Engineering Service Forecast
10.5.2 South Africa 麻豆原创 Cell Engineering Service Forecast
10.5.3 Israel 麻豆原创 Cell Engineering Service Forecast
10.5.4 Turkey 麻豆原创 Cell Engineering Service Forecast
10.6 Global Cell Engineering Service Forecast by Type (2025-2030)
10.7 Global Cell Engineering Service Forecast by Application (2025-2030)
10.7.1 GCC Countries 麻豆原创 Cell Engineering Service Forecast
11 Key Players Analysis
11.1 Portal Biotechnologies
11.1.1 Portal Biotechnologies Company Information
11.1.2 Portal Biotechnologies Cell Engineering Service Product Offered
11.1.3 Portal Biotechnologies Cell Engineering Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Portal Biotechnologies Main Business Overview
11.1.5 Portal Biotechnologies Latest Developments
11.2 Lonza Group
11.2.1 Lonza Group Company Information
11.2.2 Lonza Group Cell Engineering Service Product Offered
11.2.3 Lonza Group Cell Engineering Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Lonza Group Main Business Overview
11.2.5 Lonza Group Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific Cell Engineering Service Product Offered
11.3.3 Thermo Fisher Scientific Cell Engineering Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Sartorius
11.4.1 Sartorius Company Information
11.4.2 Sartorius Cell Engineering Service Product Offered
11.4.3 Sartorius Cell Engineering Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Sartorius Main Business Overview
11.4.5 Sartorius Latest Developments
11.5 GenScript
11.5.1 GenScript Company Information
11.5.2 GenScript Cell Engineering Service Product Offered
11.5.3 GenScript Cell Engineering Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 GenScript Main Business Overview
11.5.5 GenScript Latest Developments
11.6 Metagenomi
11.6.1 Metagenomi Company Information
11.6.2 Metagenomi Cell Engineering Service Product Offered
11.6.3 Metagenomi Cell Engineering Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Metagenomi Main Business Overview
11.6.5 Metagenomi Latest Developments
11.7 CorrectSequence Therapeutics
11.7.1 CorrectSequence Therapeutics Company Information
11.7.2 CorrectSequence Therapeutics Cell Engineering Service Product Offered
11.7.3 CorrectSequence Therapeutics Cell Engineering Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 CorrectSequence Therapeutics Main Business Overview
11.7.5 CorrectSequence Therapeutics Latest Developments
11.8 Eddie Gene
11.8.1 Eddie Gene Company Information
11.8.2 Eddie Gene Cell Engineering Service Product Offered
11.8.3 Eddie Gene Cell Engineering Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Eddie Gene Main Business Overview
11.8.5 Eddie Gene Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.